SYBX Synlogic

Synlogic Inc, formerly known as Mirna Therapeutics Inc is a clinical-stage biopharmaceutical company which is engaged in developing a pipeline of microRNA (ribonucleic acid)-based oncology therapeutics.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/01/2015
Outstanding shares:  69,709,236
Average volume:  278,218
Market cap:   $184,032,383
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87166L100
ISIN:        US87166L1008
Valuation   (See tab for details)
PE ratio:   -5.92
PB ratio:   1.12
PS ratio:   158.38
Return on equity:   -37.17%
Net income %:   -5,168.67%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy